bdf 9148 has been researched along with Cardiomyopathy, Congestive in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Böhm, M; Erdmann, E; La Rosée, K; Schmidt, U; Schulz, C; Schwinger, RH | 1 |
| Böhm, M; Erdmann, E; La Rosée, K; Mittmann, C; Schwinger, RH | 1 |
2 other study(ies) available for bdf 9148 and Cardiomyopathy, Congestive
| Article | Year |
|---|---|
Na(+)-channel activators increase cardiac glycoside sensitivity in failing human myocardium.
Topics: Adult; Azetidines; Cardiomyopathy, Dilated; Cardiotonic Agents; Drug Interactions; Female; Heart Transplantation; Humans; In Vitro Techniques; Male; Middle Aged; Myocardial Contraction; Myocardium; Ouabain; Papillary Muscles; Sodium Channels | 1992 |
Evidence for a sustained effectiveness of sodium-channel activators in failing human myocardium.
Topics: Adult; Azetidines; Cardiomyopathy, Dilated; Cardiotonic Agents; Cell Membrane; Dose-Response Relationship, Drug; Female; Heart; Humans; In Vitro Techniques; Isoproterenol; Kinetics; Male; Middle Aged; Molecular Structure; Myocardial Contraction; Myocardium; Ouabain; Piperazines; Sodium Channels | 1991 |